State Street’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.17M Buy
3,462,266
+208,362
+6% +$431K ﹤0.01% 2784
2025
Q1
$7.16M Buy
3,253,904
+107,711
+3% +$237K ﹤0.01% 2725
2024
Q4
$4.81M Sell
3,146,193
-46,243
-1% -$70.8K ﹤0.01% 3000
2024
Q3
$6.35M Sell
3,192,436
-2,088,430
-40% -$4.16M ﹤0.01% 2845
2024
Q2
$18.5M Buy
5,280,866
+2,839,996
+116% +$9.94M ﹤0.01% 2205
2024
Q1
$6.76M Sell
2,440,870
-40,975
-2% -$114K ﹤0.01% 2797
2023
Q4
$4.22M Buy
2,481,845
+80,283
+3% +$136K ﹤0.01% 3027
2023
Q3
$2.47M Buy
2,401,562
+70,324
+3% +$72.4K ﹤0.01% 3235
2023
Q2
$2.7M Sell
2,331,238
-224,755
-9% -$261K ﹤0.01% 3274
2023
Q1
$3.86M Sell
2,555,993
-30,939
-1% -$46.7K ﹤0.01% 3086
2022
Q4
$6.47M Sell
2,586,932
-6,251,774
-71% -$15.6M ﹤0.01% 2921
2022
Q3
$37.3M Sell
8,838,706
-7,490,090
-46% -$31.6M ﹤0.01% 1803
2022
Q2
$45.6M Buy
16,328,796
+3,405,427
+26% +$9.5M ﹤0.01% 1709
2022
Q1
$73.9M Buy
12,923,369
+5,230,958
+68% +$29.9M ﹤0.01% 1504
2021
Q4
$70.2M Buy
7,692,411
+1,200,504
+18% +$11M ﹤0.01% 1566
2021
Q3
$69.4M Buy
6,491,907
+1,779,188
+38% +$19M ﹤0.01% 1567
2021
Q2
$73.1M Buy
4,712,719
+128,420
+3% +$1.99M ﹤0.01% 1556
2021
Q1
$74.3M Buy
4,584,299
+602,495
+15% +$9.77M ﹤0.01% 1458
2020
Q4
$84.3M Sell
3,981,804
-428,430
-10% -$9.07M 0.01% 1278
2020
Q3
$65.4M Buy
4,410,234
+569,776
+15% +$8.44M ﹤0.01% 1259
2020
Q2
$56.5M Buy
3,840,458
+410,333
+12% +$6.04M ﹤0.01% 1379
2020
Q1
$40.3M Buy
3,430,125
+54,068
+2% +$635K ﹤0.01% 1402
2019
Q4
$79.3M Buy
3,376,057
+663,063
+24% +$15.6M 0.01% 1200
2019
Q3
$50.2M Sell
2,712,994
-1,349,319
-33% -$25M ﹤0.01% 1435
2019
Q2
$75.5M Buy
4,062,313
+829,686
+26% +$15.4M 0.01% 1220
2019
Q1
$79M Sell
3,232,627
-253,365
-7% -$6.19M 0.01% 1170
2018
Q4
$90.4M Buy
3,485,992
+236,508
+7% +$6.14M 0.01% 959
2018
Q3
$103M Sell
3,249,484
-217,402
-6% -$6.88M 0.01% 1059
2018
Q2
$135M Buy
3,466,886
+323,336
+10% +$12.6M 0.01% 860
2018
Q1
$86.8M Buy
3,143,550
+914,527
+41% +$25.2M 0.01% 1089
2017
Q4
$40.3M Buy
2,229,023
+308,202
+16% +$5.58M ﹤0.01% 1572
2017
Q3
$31M Buy
1,920,821
+183,512
+11% +$2.96M ﹤0.01% 1708
2017
Q2
$24.1M Sell
1,737,309
-50,369
-3% -$698K ﹤0.01% 1853
2017
Q1
$26.8M Buy
1,787,678
+420,113
+31% +$6.3M ﹤0.01% 1732
2016
Q4
$17.9M Buy
1,367,565
+270,022
+25% +$3.54M ﹤0.01% 1981
2016
Q3
$18.9M Buy
1,097,543
+103,311
+10% +$1.78M ﹤0.01% 1808
2016
Q2
$17.9M Sell
994,232
-214,340
-18% -$3.87M ﹤0.01% 1830
2016
Q1
$22.9M Sell
1,208,572
-215,739
-15% -$4.1M ﹤0.01% 1631
2015
Q4
$38M Buy
1,424,311
+326,874
+30% +$8.73M ﹤0.01% 1309
2015
Q3
$26.8M Sell
1,097,437
-101,140
-8% -$2.47M ﹤0.01% 1553
2015
Q2
$37.3M Buy
1,198,577
+900,822
+303% +$28.1M ﹤0.01% 1439
2015
Q1
$4.34M Buy
297,755
+68,163
+30% +$992K ﹤0.01% 2638
2014
Q4
$2.31M Buy
229,592
+15,227
+7% +$153K ﹤0.01% 2979
2014
Q3
$1.78M Buy
214,365
+29,203
+16% +$243K ﹤0.01% 3066
2014
Q2
$2.28M Buy
185,162
+172,762
+1,393% +$2.13M ﹤0.01% 3003
2014
Q1
$173K Buy
+12,400
New +$173K ﹤0.01% 3474